Long term cryopreservation in 5% DMSO maintains unchanged CD34+ cells viability and allows satisfactory hematological engraftment after peripheral blood stem cell transplantation

被引:18
作者
Abbruzzese, L. [1 ]
Agostini, F. [1 ]
Durante, C. [1 ]
Toffola, R. T. [1 ]
Rupolo, M. [2 ]
Rossi, F. M. [3 ]
Lleshi, A. [2 ]
Zanolin, S. [1 ]
Michieli, M. [2 ]
Mazzucato, M. [1 ]
机构
[1] IRCCS, Ctr Riferimento Oncol, Dipartimento Lab Diagnost & Terapie Cellulari, Unita Raccolta & Manipolaz Cellule Staminali, Aviano, Italy
[2] IRCCS, Ctr Riferimento Oncol, Dipartimento Oncol Med, Unita Terapia Cellulare & Alte Dosi, Aviano, Italy
[3] IRCCS, Ctr Riferimento Oncol, Unita Oncoematol Clin & Sperimentale, Dipartimento Lab Diagnost & Terapie Cellulari, Aviano, Italy
关键词
5% DMSO; CD34+viability; engraftment; EVA-teflon double bags; long-term cryopreservation; PROGENITOR CELLS; DIMETHYL-SULFOXIDE; HEMATOPOIETIC STEM;
D O I
10.1111/vox.12012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peripheral blood stem cell cryopreservation is associated with cell damage and decreased viability. We evaluated the impact of up to 10years of cryopreservation (5% DMSO) on viability of CD34+ cells utilizing graft samples of consecutive patients (2002-2012) with different malignancies who underwent stem cell collection and transplantation. Viability of CD34+ cells from oncohaematological patients measured after 5weeks (97 center dot 2 +/- 0 center dot 6%) or after 9-10years of cryopreservation (95 center dot 9 +/- 0 center dot 5%) was unaffected. Haemoglobin, granulocyte and platelet recovery after transplantation of long-term cryopreserved grafts occurred within 8-13days. CD34+ stem cells can be safely stored up to 9-10years, without affecting cell viability and clinical effectiveness.
引用
收藏
页码:77 / 80
页数:4
相关论文
共 12 条
[1]   A new freezing and storage procedure improves safety and viability of haematopoietic stem cells and neutrophil engraftment: a single institution experience [J].
Abbruzzese, L. ;
Michieli, M. ;
Rupolo, M. ;
Toffola, R. Tassan ;
Da Ponte, A. ;
Rossi, F. M. ;
Lorenzon, D. ;
Simonelli, C. ;
Gattei, V. ;
De Marco, L. ;
Mazzucato, M. .
VOX SANGUINIS, 2010, 98 (02) :172-180
[2]   Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation [J].
Akkok, Cigdem A. ;
Liseth, Knut ;
Nesthus, Ingerid ;
Lokeland, Turid ;
Tefre, Kari ;
Bruserud, Oystein ;
Abrahamsen, Jenny F. .
TRANSFUSION, 2008, 48 (05) :877-883
[3]   Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte- and platelet-derived soluble mediators [J].
Akkok, Cigdem Akalin ;
Liseth, Knut ;
Hervig, Tor ;
Ryningen, Anita ;
Bruserud, Oystein ;
Ersvaer, Elisabeth .
CYTOTHERAPY, 2009, 11 (06) :749-760
[4]   Viability of cryopreserved BM progenitor cells stored for more than a decade [J].
Donnenberg, AD ;
Koch, EK ;
Griffin, DL ;
Stanczak, HM ;
Kiss, JE ;
Carlos, TM ;
BuchBarker, DM ;
Yeager, AM .
CYTOTHERAPY, 2002, 4 (02) :157-163
[5]  
Keeney M, 1998, CYTOMETRY, V34, P61, DOI 10.1002/(SICI)1097-0320(19980415)34:2<61::AID-CYTO1>3.0.CO
[6]  
2-F
[7]   Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts [J].
Kim, Dong Hwan ;
Jamal, Nazir ;
Saragosa, Ronnie ;
Loach, David ;
Wright, Janice ;
Gupta, Vikas ;
Kuruvilla, John ;
Lipton, Jeffrey H. ;
Minden, Mark ;
Messner, Hans A. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (10) :1233-1243
[8]   Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood [J].
Meyer, T. P. H. ;
Hofmann, B. ;
Zaisserer, J. ;
Jacobs, V. R. ;
Fuchs, B. ;
Rapp, S. ;
Weinauer, F. ;
Burkhart, J. .
CYTOTHERAPY, 2006, 8 (03) :265-276
[9]   PROLONGED CRYOPRESERVATION OF HUMAN-GRANULOCYTES [J].
RICHMAN, CM .
TRANSFUSION, 1983, 23 (06) :508-511
[10]  
Santos George W., 1994, Current Opinion in Oncology, V6, P115, DOI 10.1097/00001622-199403000-00001